News

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...
Novo Nordisk is likely to draw investor attention on Monday after the company said it is moving forward with the oral and ...
Novo Nordisk sees soaring demand for Ozempic and Wegovy as label expansions and manufacturing boosts fuel obesity market ...
GLP-1 drugs like Ozempic and Wegovy change food cravings and taste preferences—leading to weight loss beyond just reduced ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Wegovy can help people with excess weight and obesity lose weight and improve their health. And you don’t need to drive to a ...
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - Wegovy users could lose more than 10% of their body weight after a year on the ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
More than a dozen lawsuits filed in New York and New Jersey claim that weight-loss drugs like Wegovy and Ozempic caused ...